Strasser Kathryn, Moeller-Saxone Kristen, Meadows Graham, Hocking Barbara, Stanton John, Kee Pat
SANE Australia, Melbourne, Victoria.
Aust Fam Physician. 2002 Jan;31(1):21-4.
The rate of cigarette smoking in people with schizophrenia is up to three times that of the general population, and causes much ill health and high mortality rates. There are physiological and pharmacological interactions between the symptoms of schizophrenia, antipsychotic medication and smoking which contribute to this high rate and make it more difficult for those with schizophrenia to cease smoking.
This article aims to inform general practitioners of the extent and nature of the problem, and ways to assist people with schizophrenia to reduce/cease smoking.
Patients with schizophrenia often experience physical, financial and social disadvantages because of their illness. Actively encouraging and assisting smoking reduction/cessation is important to improve their quality of life as well as longevity.
精神分裂症患者的吸烟率高达普通人群的三倍,会导致诸多健康问题和高死亡率。精神分裂症症状、抗精神病药物与吸烟之间存在生理和药理相互作用,这导致了如此高的吸烟率,也使得精神分裂症患者更难戒烟。
本文旨在让全科医生了解该问题的程度和性质,以及帮助精神分裂症患者减少/戒烟的方法。
精神分裂症患者常因其疾病而在身体、经济和社会方面处于不利地位。积极鼓励和协助减少吸烟/戒烟对于提高他们的生活质量和延长寿命很重要。